KEMEDIUM SIGNALFINANCIAL10-K

KE achieved significant debt reduction of 50% and doubled operating cash flow, but this came alongside declining revenues as evidenced by lower gross profit and reduced inventory levels.

The company appears to be executing a deliberate deleveraging strategy, cutting debt in half while generating strong cash flows, which substantially improves financial flexibility and reduces interest burden. However, the 26% decline in gross profit suggests meaningful revenue contraction, indicating KE may be rightsizing operations or facing demand headwinds that offset the positive debt management.

Comparing 2025-08-22 vs 2024-08-23View on EDGAR →
FINANCIAL ANALYSIS

KE demonstrated strong balance sheet improvement with debt falling 50% to $147M and operating cash flow surging 151% to $184M, while interest expense dropped 35%. However, the company experienced revenue decline as shown by gross profit falling 26% to $104M, accompanied by inventory reduction of 19% and lower current assets, suggesting either successful demand management or weakening business conditions. The overall picture shows a company prioritizing financial health through debt reduction and cash generation while managing through what appears to be a revenue downturn.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
+322.6%
$2.8M$12.0M

Share repurchases increased 322.6% — management returning capital, signals confidence in intrinsic value.

Operating Cash Flow
Cash Flow
+151.2%
$73.2M$183.9M

Operating cash flow surged 151.2% — exceptional cash generation, highest quality earnings signal.

Total Debt
Balance Sheet
-50.1%
$294.8M$147.1M

Debt reduced 50.1% — deleveraging strengthens balance sheet and reduces financial risk.

Interest Expense
P&L
-35.4%
$22.8M$14.7M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Capital Expenditure
Cash Flow
-27.8%
$46.1M$33.3M

Capex reduced 27.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Gross Profit
P&L
-25.6%
$140.3M$104.4M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

SG&A Expense
P&L
-24.5%
$66.6M$50.3M

SG&A reduced 24.5% — improved cost efficiency or headcount reduction improving operating margins.

Inventory
Balance Sheet
-19.1%
$338.1M$273.5M

Inventory reduced 19.1% — lean inventory management or demand outpacing supply.

Current Assets
Balance Sheet
-17.4%
$847.0M$699.6M

Current assets declined 17.4% — monitor working capital adequacy and short-term liquidity.

Net Income
P&L
-17.2%
$20.5M$17.0M

Net income declined 17.2% — review whether driven by operations, interest costs, or non-recurring items.

LANGUAGE CHANGES
NEW — 2025-08-22
PRIOR — 2024-08-23
ADDED
We deliver a package of value that includes durable, high-reliability electronics, higher level and final assemblies, and contract manufacturing organization ( CMO ) solutions.
Our CMO solutions support the production of medical disposables and drug delivery devices, from precision molded plastics and cold chain management to drug integration.
Customers and industry trade publications regularly award us for our design and manufacturing expertise that, coupled with robust processes and procedures, help us ensure that we deliver the highest levels of quality, reliability, and innovative service throughout the entire life cycle of our customers products.
Our Customer Relationship Management ( CRM ) model is key to providing our customers convenient access to our highly integrated global footprint, enabled by our largely standardized operating system and procedures.
As of June 30, 2025, all of our operating segments provided contract manufacturing services, including engineering and supply chain support, for the production of electronic assemblies and other products including medical devices, medical disposables, and precision molded plastics primarily in automotive, medical, and industrial applications, to the specifications and designs of our customers.
+7 more — sign up free →
REMOVED
We deliver a package of value that begins with our core competency of producing durable electronics and further offer contract manufacturing services for non-electronic components, medical disposables, drug delivery solutions and precision molded plastics.
Our design and manufacturing expertise coupled with robust processes and procedures help us ensure that we deliver the highest levels of quality and reliability throughout the entire life cycle of our customers products.
We deliver award-winning service across our global footprint with an operations platform driven by highly integrated procedures, standardization, and teamwork.
Our Customer Relationship Management ( CRM ) model is key to providing our customers convenient access to our global footprint and all of our services throughout the entire product life cycle.
For over 35 years, we have manufactured safety-critical electronic assemblies for automotive customers, developing invaluable expertise that extends beyond the automotive industry to benefit our medical and industrial customers as well.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →